A patient is on an Oral anticoagulant (Warfarin) for treatment of pulmonary embolism. You will monitor the adequacy of anticoagulation by:

Appeared in: GMCH - 2016

Explanation

Warfarin is a vitamin K antagonist, an oral anticoagulant whose effectiveness is monitored using the International Normalized Ratio (INR).
The INR is a standardized calculation based on the prothrombin time (PT) test, which ensures consistent and comparable results across different laboratories.
For a patient with pulmonary embolism, the target therapeutic INR range is typically 2.0 to 3.0, balancing anticoagulation efficacy with bleeding risk.

Option A: The Modified Ivy Test assesses primary hemostasis, specifically platelet function and bleeding time. It does not measure the effects of Warfarin on the coagulation cascade's clotting factors.
Option B: The Activated Partial Thromboplastin Time (APTT or aPTT) measures the intrinsic and common pathways of coagulation. It is the standard test for monitoring therapy with unfractionated heparin.
Option C: The Indirect Coombs' Test is an immunological test that detects circulating antibodies against red blood cells. It is entirely unrelated to blood coagulation or anticoagulant therapy.

Clinical Relevance

Nursing practice connection: Use the key finding related to Laboratory monitoring of Warfarin therapy to guide bedside assessment, documentation, and the next nursing action.
Nurses are responsible for monitoring INR results, administering the correct Warfarin dose based on orders, and assessing the patient for signs of bleeding (e.g., bruising, hematuria) or thrombosis (e.g., leg swelling, chest pain).
Patient education is a key nursing role, including teaching about the importance of consistent dietary Vitamin K intake, adherence to the medication schedule, and recognizing signs of bleeding to report immediately.
An INR below the therapeutic range (e.g., less than 2.0) indicates inadequate anticoagulation and a high risk of clot formation, while an INR above the range (e.g., greater than 3.0) signifies an excessive anticoagulant effect and a high risk of hemorrhage.

How to Approach the Question

First, identify the key medication in the question stem, which is 'Warfarin'.
Next, recall the classification and primary use of this drug. Warfarin is a widely used oral anticoagulant.
Access your knowledge base on pharmacological monitoring. A crucial and frequently tested concept is the pairing of specific anticoagulants with their corresponding lab tests.
Remember the mnemonic or association: 'Warfarin goes with PT/INR' and 'Heparin goes with aPTT'.
Scan the options provided. Option D, 'International Normalized Ratio (INR)', is the direct and correct test for Warfarin.
Briefly review the other options to confirm they are incorrect. APTT is for heparin, the Ivy test is for platelets, and the Coombs' test is for immunology, confirming your choice.

Concept Tested & Keywords

Concept Tested: Laboratory monitoring of Warfarin therapy.
Stem keywords: Oral anticoagulant, Warfarin, pulmonary embolism, monitor, anticoagulation
Lead-in keywords: monitor the adequacy
Clinical cues: Patient on Warfarin for pulmonary embolism
Negative lead-in flag: false

QRZKTCzosXpb8TXvnuU_rr

E6 Medicine Harrison 22e Part 1 p. 992-994

E6 Nursing Brunner Adult Health 3SA Vol 1 Part 3 p. 79-81

E6 Pharmacology Nursing Lilley 11e Part 2 p. 125-127

Practise the full GMCH - 2016

Attempt every question from this paper in a timed mock, then review the full solution for each one.